➤ Subscribe for Complete Access

Flexible subscription options to meet your unique needs…

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Colorcon
Harvard Business School
Baxter
Express Scripts
Medtronic

Last Updated: November 27, 2021

DrugPatentWatch Database Preview

Details for Patent: 7,146,978


Email this page to a colleague

« Back to Dashboard

Summary for Patent: 7,146,978
Title:Inhalation device and method
Abstract: Inhalation device and associated method for facilitating inhalation by a patient of powder medicaments contained in a receptacle. The inhalation device has a chamber for receiving the receptacle. A ring is circumferentially coupled to an inner surface of the chamber to achieve a higher reproducible emitted dose of medicament from the receptacle. The inhalation device also includes an improved implement for puncturing the receptacle, requiring less force and experiencing fewer failures.
Inventor(s): Edwards; David (Boston, MA), DeLong; Mark (Newton, MA), Dunbar; Craig (Boston, MA), Penachio; Ernest E. (Haverhill, MA), Stapleton; Kevin (Seattle, WA), Wolff; Mark (Somerville, MA)
Assignee: Advanced Inhalation Research, Inc. (Cambridge, MA)
Application Number:10/771,447
Patent Claim Types:
see list of patent claims
Use; Device;

Drugs Protected by US Patent 7,146,978

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Acorda INBRIJA levodopa POWDER;INHALATION 209184-001 Dec 21, 2018 RX Yes Yes ⤷  Try it Free ⤷  Try it Free INTERMITTENT TREATMENT OF OFF EPISODES IN PATIENTS WITH PARKINSON'S DISEASE WITH A POWDER INHALER ⤷  Try it Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 7,146,978

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 316397 ⤷  Try it Free
Austria 394136 ⤷  Try it Free
Australia 2002255808 ⤷  Try it Free
Australia 2002334929 ⤷  Try it Free
Canada 2444129 ⤷  Try it Free
Canada 2477653 ⤷  Try it Free
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Merck
Baxter
Medtronic
Johnson and Johnson
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.